PURA VIDA INVESTMENTS, LLC - Q1 2017 holdings

$338 Million is the total value of PURA VIDA INVESTMENTS, LLC's 79 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 100.0% .

 Value Shares↓ Weighting
SPY SellSPDR S&P 500 ETF TRput$11,787,000
-39.7%
50,000
-42.9%
3.49%
-51.4%
HOLX BuyHOLOGIC INC$10,744,000
+24.9%
252,500
+17.8%
3.18%
+0.7%
BIO BuyBIO RAD LABS INCcl a$10,565,000
+90.0%
53,000
+73.8%
3.12%
+53.3%
BAX BuyBAXTER INTL INC$9,335,000
+40.4%
180,000
+20.0%
2.76%
+13.2%
BCR BuyBARD C R INC$9,320,000
+13.7%
37,500
+2.7%
2.76%
-8.3%
BSX SellBOSTON SCIENTIFIC CORP$9,078,000
+10.5%
365,000
-3.9%
2.68%
-10.9%
EVHC SellENVISION HEALTHCARE CORP$8,585,000
-4.2%
140,000
-1.2%
2.54%
-22.8%
GMED BuyGLOBUS MED INCcl a$8,461,000
+70.5%
285,646
+42.8%
2.50%
+37.5%
EXAS NewEXACT SCIENCES CORP$8,267,000350,000
+100.0%
2.44%
GSK NewGLAXOSMITHKLINE PLCsponsored adr$8,248,000195,625
+100.0%
2.44%
ALXN NewALEXION PHARMACEUTICALS INC$8,184,00067,500
+100.0%
2.42%
UNH SellUNITEDHEALTH GROUP INC$7,790,000
-22.1%
47,500
-24.0%
2.30%
-37.2%
ABT NewABBOTT LABScall$7,772,000175,000
+100.0%
2.30%
CNC NewCENTENE CORP DEL$7,731,000108,491
+100.0%
2.29%
ICUI BuyICU MED INC$7,635,000
+130.3%
50,000
+122.2%
2.26%
+85.8%
NXTM BuyNXSTAGE MEDICAL INC$7,378,000
+9.3%
275,000
+6.8%
2.18%
-11.8%
PKI NewPERKINELMER INC$6,938,000119,500
+100.0%
2.05%
AGN BuyALLERGAN PLC$6,899,000
+390.3%
28,875
+331.0%
2.04%
+295.3%
ABT NewABBOTT LABS$6,884,000155,000
+100.0%
2.04%
UHS NewUNIVERSAL HLTH SVCS INCcl b$6,845,00055,000
+100.0%
2.02%
SHPG NewSHIRE PLCsponsored adr$6,817,00039,125
+100.0%
2.02%
XENT NewINTERSECT ENT INC$6,653,000387,922
+100.0%
1.97%
IVC BuyINVACARE CORP$6,248,000
+114.3%
525,010
+135.0%
1.85%
+72.9%
FXH BuyFIRST TR EXHANGE TRADED FDput$6,242,000
+81.6%
100,000
+66.7%
1.85%
+46.5%
TFX NewTELEFLEX INC$5,812,00030,000
+100.0%
1.72%
AXGT NewAXOVANT SCIENCES LTD$5,677,000380,000
+100.0%
1.68%
AVXS BuyAVEXIS INC$5,522,000
+120.9%
72,625
+38.7%
1.63%
+78.1%
CELG NewCELGENE CORP$5,475,00044,000
+100.0%
1.62%
WAT NewWATERS CORPcall$5,471,00035,000
+100.0%
1.62%
WMGI BuyWRIGHT MED GROUP N V$5,446,000
+69.3%
175,000
+25.0%
1.61%
+36.6%
LLY NewLILLY ELI & CO$5,404,00064,250
+100.0%
1.60%
SUPN BuySUPERNUS PHARMACEUTICALS INC$5,399,000
+288.7%
172,500
+213.6%
1.60%
+213.8%
ABBV SellABBVIE INC$5,384,000
-42.8%
82,625
-45.1%
1.59%
-53.9%
PEN SellPENUMBRA INC$5,220,000
-13.9%
62,555
-34.2%
1.54%
-30.5%
IWM SellISHARES TRput$5,156,000
-36.3%
37,500
-37.5%
1.52%
-48.6%
QGEN NewQIAGEN NV$4,418,000152,500
+100.0%
1.31%
MEDP BuyMEDPACE HLDGS INC$4,337,000
+17.3%
145,282
+41.7%
1.28%
-5.3%
ABMD NewABIOMED INCcall$4,257,00034,000
+100.0%
1.26%
SIEN BuySIENTRA INC$4,250,000
-0.2%
504,799
+1.0%
1.26%
-19.5%
PODD NewINSULET CORP$4,191,00097,256
+100.0%
1.24%
KTWO SellK2M GROUP HLDGS INC$4,162,000
-14.3%
202,907
-16.2%
1.23%
-30.8%
ADMS NewADAMAS PHARMACEUTICALS INC$4,156,000237,500
+100.0%
1.23%
TEVA NewTEVA PHARMACEUTICAL INDS LTDadr$4,007,000124,875
+100.0%
1.18%
XLV SellSELECT SECTOR SPDR TRput$3,718,000
-68.7%
50,000
-71.0%
1.10%
-74.8%
IMMU BuyIMMUNOMEDICS INC$3,526,000
+185.5%
545,000
+62.0%
1.04%
+130.2%
SUPN NewSUPERNUS PHARMACEUTICALS INCput$3,287,000105,000
+100.0%
0.97%
ARAY BuyACCURAY INC$3,254,000
+136.8%
685,100
+129.3%
0.96%
+90.9%
DXCM NewDEXCOM INC$2,966,00035,000
+100.0%
0.88%
NSTG SellNANOSTRING TECHNOLOGIES INC$2,836,000
-21.2%
142,750
-11.5%
0.84%
-36.4%
BuyNEURODERM LTD$2,757,000
+54.9%
103,850
+29.5%
0.82%
+24.8%
GBT NewGLOBAL BLOOD THERAPEUTICS IN$2,233,00060,598
+100.0%
0.66%
COLL NewCOLLEGIUM PHARMACEUTICAL INC$2,012,000200,000
+100.0%
0.60%
ARRY BuyARRAY BIOPHARMA INC$1,994,000
+44.2%
223,000
+41.7%
0.59%
+16.4%
CLVS NewCLOVIS ONCOLGY INC$1,990,00031,250
+100.0%
0.59%
PCRX NewPACIRA PHARMACEUTICALS INC$1,938,00042,500
+100.0%
0.57%
OTIC NewOTONOMY INC$1,684,000137,500
+100.0%
0.50%
AIMT NewAIMMUNE THERAPEUTICS INC$1,521,00070,000
+100.0%
0.45%
JAZZ NewJAZZ PHARMACEUTICALS PLC$1,480,00010,200
+100.0%
0.44%
ANIP BuyANI PHARMACEUTICALS INC$1,430,000
-10.1%
28,875
+10.0%
0.42%
-27.4%
ARDX NewAEDELYX INC$1,297,000102,500
+100.0%
0.38%
VIVE BuyVIVEVE MED INC$1,229,000
+52.1%
194,132
+23.7%
0.36%
+22.6%
ADMP NewADAMIS PHARMACEUTICALS CORP$956,000225,000
+100.0%
0.28%
FLXN NewFLEXION THERAPEUTICS INC$942,00035,000
+100.0%
0.28%
SGYPQ NewSYNERGY PHARMACEUTICALS DELcall$932,000200,000
+100.0%
0.28%
WMGIZ BuyWRIGHT MED GROUP N Vright 03/01/2019$899,000
+16.0%
587,241
+0.1%
0.27%
-6.3%
ALQA BuyALLIQUA BIOMEDICAL INC$610,000
+77.3%
1,208,026
+107.2%
0.18%
+42.9%
ZYNE NewZYNERBA PHARMACEUTICALS INC$603,00030,000
+100.0%
0.18%
ELGX NewENDOLOGIX INCcall$547,00075,500
+100.0%
0.16%
AGRX  AGILE THERAPEUTICS INC$527,000
-43.8%
164,5010.0%0.16%
-54.7%
NewNEOVASC INC$520,000340,000
+100.0%
0.15%
AXGN BuyAXOGEN INC$519,000
+133.8%
49,700
+101.2%
0.15%
+88.9%
STML NewSTEMLINE THERAPEUTICS INC$513,00060,000
+100.0%
0.15%
STDY  STEADYMED LTD$461,000
+122.7%
79,4340.0%0.14%
+78.9%
FPRX SellFIVE PRIME THERAPEUTICS INC$325,000
-54.2%
8,982
-36.5%
0.10%
-63.1%
ARAY NewACCURAY INCcall$238,00050,000
+100.0%
0.07%
FOMX SellFOAMIX PHARMACEUTICALS LTD$119,000
-92.2%
24,100
-82.4%
0.04%
-93.7%
FOMX NewFOAMIX PHARMACEUTICALS LTDcall$94,00018,900
+100.0%
0.03%
HSGX  HISTOGENICS CORP$23,0000.0%13,5260.0%0.01%
-12.5%
ELGX ExitENDOLOGIX INCput$0-4,600
-100.0%
-0.01%
NXTM ExitNXSTAGE MEDICAL INCcall$0-10,600
-100.0%
-0.10%
BVX ExitBOVIE MEDICAL CORP$0-123,000
-100.0%
-0.16%
OCRX ExitOCERA THERAPEUTICS INC$0-258,893
-100.0%
-0.20%
XENT ExitINTERSECT ENT INCcall$0-3,000
-100.0%
-0.24%
ALDX ExitALDEYRA THERAPEUTICS INC$0-125,000
-100.0%
-0.24%
AMRN ExitAMARIN CORP PLCspons adr new$0-250,000
-100.0%
-0.28%
QSII ExitQUALITY SYS INCcall$0-145,300
-100.0%
-0.70%
EWA ExitISHAREScall$0-100,000
-100.0%
-0.74%
XRAY ExitDENTSPLY SIRONA INC$0-47,500
-100.0%
-1.00%
LPNT ExitLIFEPOINT HEALTH INCput$0-50,000
-100.0%
-1.04%
ELGX ExitENDOLOGIX INC$0-500,000
-100.0%
-1.05%
CFMS ExitCONFORMIS INC$0-419,235
-100.0%
-1.24%
QSII ExitQUALITY SYS INC$0-266,617
-100.0%
-1.28%
GWPH ExitGW PHARMACEUTICALS PLCads$0-32,250
-100.0%
-1.32%
GKOS ExitGLAUKOS CORP$0-109,903
-100.0%
-1.38%
TMO ExitTHERMO FISHER SCIENTIFIC INCput$0-30,000
-100.0%
-1.55%
BSX ExitBOSTON SCIENTIFIC CORPcall$0-200,000
-100.0%
-1.59%
INGN ExitINOGEN INCput$0-65,000
-100.0%
-1.60%
ILMN ExitILLUMINA INC$0-35,000
-100.0%
-1.64%
CYNO ExitCYNOSURE INCcl a$0-100,000
-100.0%
-1.67%
AET ExitAETNA INC NEW$0-39,000
-100.0%
-1.77%
SYK ExitSTRYKER CORPput$0-50,000
-100.0%
-2.20%
HUM ExitHUMANA INC$0-33,500
-100.0%
-2.51%
NUVA ExitNUVASIVE INC$0-105,000
-100.0%
-2.59%
IEV ExitISHARES TReurope etf$0-186,000
-100.0%
-2.65%
AGN ExitALLERGAN PLCput$0-40,000
-100.0%
-3.08%
ATHN ExitATHENAHEALTH INC$0-95,000
-100.0%
-3.66%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13
SC 13D/A2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings